Evidence map›Paper›PMID 25495870›Full record

ArticlePhotochemistry and photobiology

Thioredoxin reductase activity may be more important than GSH level in protecting human lens epithelial cells against UVA light.

Vanita A Padgaonkar, Victor R Leverenz, Aparna V Bhat, Sara E Pelliccia, Frank J Giblin

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Vanita A PadgaonkarEye Research Institute, Oakland University, Rochester, MI.
Victor R Leverenz
Aparna V Bhat
Sara E Pelliccia
Frank J Giblin
Smith-Kettlewell Eye Research Institute · USOakland University · US

Funding

PROTEINS OF NORMAL AND CATARACTOUS LENSESR01EY002027 · NEI · OAKLAND UNIVERSITY · PI GIBLIN, FRANK JOSEPH · 1985 to 2017
$6.1M
NEI NIH HHS EY02027NEI NIH HHS R01 EY002027
6 · The paper itself

Abstract

This study compares the abilities of the glutathione (GSH) and thioredoxin (Trx) antioxidant systems in defending cultured human lens epithelial cells (LECs) against UVA light. Levels of GSH were depleted with either L-buthionine-(S,R)-sulfoximine (BSO) or 1-chloro-2,4-dinitrobenzene (CDNB). CDNB treatment also inhibited the activity of thioredoxin reductase (TrxR). Two levels of O2 , 3% and 20%, were employed during a 1 h exposure of the cells to 25 J cm(-2) of UVA radiation (338-400 nm wavelength, peak at 365 nm). Inhibition of TrxR activity by CDNB, combined with exposure to UVA light, produced a substantial loss of LECs and cell damage, with the effects being considerably more severe at 20% O2 compared to 3%. In contrast, depletion of GSH by BSO, combined with exposure to UVA light, produced only a slight cell loss, with no apparent morphological effects. Catalase was highly sensitive to UVA-induced inactivation, but was not essential for protection. Although UVA light presented a challenge for the lens epithelium, it was well tolerated under normal conditions. The results demonstrate an important role for TrxR activity in defending the lens epithelium against UVA light, possibly related to the ability of the Trx system to assist DNA synthesis following UVA-induced cell damage.

Indexed as

CatalaseCell CountCell Line, TransformedCell SurvivalDinitrochlorobenzeneEpithelial CellsGlutathioneHumansLens, CrystallineMethionine SulfoximineOxidative StressOxygenThioredoxin Reductase 1ThioredoxinsUltraviolet Raysbuthionine sulfoximine ethyl esterCatalaseDinitrochlorobenzeneGlutathioneMethionine SulfoximineOxygenThioredoxin Reductase 1ThioredoxinsTXN protein, humanTXNRD1 protein, human

Identifiers

PMID25495870
PMCPMC4355078
OpenAlexW2070062560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.